Showing results (281-290 of 291) with videos related to
Sort By:
Pageof 30
Cell Death & Disease|August 12, 2016
Golgi-associated LC3 lipidation requires V-ATPase in noncanonical autophagyYing Gao, Yajun Liu, Liang Hong, et al.Cancer Letters|May 5, 2023
Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancerJiaye Lu, Jingwei Li, Ziyou Lin, et al.Cell Death & Disease|July 27, 2021
HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activityWenwei Luo, Jingyan Li, Ziqing Li, et al.Pharmacological Reviews|June 5, 2021
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to PharmacotherapiesSuowen Xu, Iqra Ilyas, Peter J Little, et al.Cancer Research|October 23, 2025
RORγ Hijacks HIF-1α to Promote Peritoneal Metastasis of Gastric CancerQianqian Wang, Lin Zhong, Xiaojuan Wang, et al.Cell Reports. Medicine|May 1, 2024
Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcomaJianwei Zheng, Qianqian Wang, Jianghe Chen, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 2012
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and functionSisi Lin, Chun Zhou, Edward Neufeld, et al.Redox Biology|April 28, 2022
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancerShumin Ouyang, Huaxuan Li, Linlin Lou, et al.Acta Pharmaceutica Sinica. B|December 23, 2020
Targeting castration-resistant prostate cancer with a novel ROR<i>γ</i> antagonist elaiophylinJianwei Zheng, Junfeng Wang, Qian Wang, et al.Cell Death & Disease|February 20, 2022
Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancerLin Zhong, Bin Yang, Zhenhua Zhang, et al.Pageof 30